Mucosal vaccines and technology

There is an urgent and unmet need to develop effective vaccines to reduce the global burden of infectious disease in both animals and humans, and in particular for the majority of pathogens that infect via mucosal sites. Here we summarise the impediments to developing mucosal vaccines and review the...

Descripción completa

Detalles Bibliográficos
Autores principales: Miquel‐Clopés, A., Bentley, E. G., Stewart, J. P., Carding, S. R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Vaccines for Emerging Pathogens: from Research to the Clinic. Part 1. Series Editor: E Diane Williamson
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468177/
https://www.ncbi.nlm.nih.gov/pubmed/30963541
http://dx.doi.org/10.1111/cei.13285
Descripción
Sumario:There is an urgent and unmet need to develop effective vaccines to reduce the global burden of infectious disease in both animals and humans, and in particular for the majority of pathogens that infect via mucosal sites. Here we summarise the impediments to developing mucosal vaccines and review the new and emerging technologies aimed at overcoming the lack of effective vaccine delivery systems that is the major obstacle to developing new mucosal vaccines.

Ejemplares similares